I am a bit confused. Hottod posted "Acadia’s quoted average net price per patient of US$375,000 per annum is the net expected realised sales amount per patient after deductions for factors such as different dosing based on weight, rebates, non-compliance etc. Net sales is what Acadia will be reporting as sales in its accounts".
No one seems to take into account this huge cost of treatment in revenue estimates. Am I missing something? I hope so.
I am a bit confused. Hottod posted "Acadia’s quoted average net...
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |